Three types of self-efficacy associated with medication adherence in patients with co-occurring HIV and substance use disorders, but only when mood disorders are present

被引:16
|
作者
Reif, Susan [1 ]
Proeschold-Bell, Rae Jean [1 ,2 ]
Yao, Jia [1 ]
LeGrand, Sara [1 ,2 ]
Uehara, Anna [2 ]
Asiimwe, Edgar [2 ]
Quinlivan, Evelyn Byrd [3 ]
机构
[1] Duke Univ, Duke Ctr Hlth Policy & Inequal Res, Durham, NC USA
[2] Duke Univ, Duke Global Hlth Inst, 2812 Erwin Rd,Suite 403, Durham, NC 27705 USA
[3] Univ North Carolina Chapel Hill, Ctr Infect Dis, Chapel Hill, NC USA
来源
JOURNAL OF MULTIDISCIPLINARY HEALTHCARE | 2013年 / 6卷
关键词
human immunodeficiency virus; self-efficacy; substance use; depression; anxiety; interventions;
D O I
10.2147/JMDH.S44204
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Adherence with medication regimens for human immunodeficiency virus (HIV) is a life-saving behavior for people with HIV infection, yet adherence is challenging for many individuals with co-occurring substance use and/or mood disorders. Medication-taking self-efficacy, which is the confidence that one can take one's medication as prescribed, is associated with better adherence with HIV medication. However, little is known about the influence that other kinds of self-efficacy have on adherence with HIV medication, especially among HIV-infected individuals with co-occurring substance use and/or mood disorders. We sought to examine the relationship between adherence with HIV medication among substance users and three specific kinds of self-efficacy, ie, one's confidence that one can communicate with medical providers, get support, and manage one's mood. We further sought to examine whether symptoms of depression and anxiety moderate these relationships. Methods: Patients were recruited from three HIV clinics in the southeastern United States as part of an integrated study of treatment for HIV and substance use. Results: We interviewed 154 patients with HIV and substance use who reported taking HIV medications. Based on symptoms of depression and anxiety using the Patient Health Questionnaire-9 and the Hospital Anxiety and Depression Scale-Anxiety, 63% had probable depression and/or anxiety. Higher levels of self-efficacy in provider communication (beta = 3.86,P < 0.01), getting needed support (beta = 2.82, P < 0.01), and mood management (beta = 2.29, P < 0.05) were related to better self-reported adherence with HIV medication among study participants with probable depression and/or anxiety. The three kinds of self-efficacy were not associated with medication adherence among participants with HIV and substance use only. Conclusion: In the search for mutable factors to improve medication adherence among individuals triply diagnosed with HIV, substance use, and mood disorders, these findings support previous research indicating the benefit of enhancing self-efficacy, and further point to three specific kinds of self-efficacy that may benefit medication adherence, ie, provider communication, getting support, and mood management.
引用
收藏
页码:229 / 237
页数:9
相关论文
共 50 条
  • [1] Behavioral therapies for co-occurring substance use and mood disorders
    Carroll, KM
    BIOLOGICAL PSYCHIATRY, 2004, 56 (10) : 778 - 784
  • [2] Profiles Associated Respectively with Substance Dependence Only, Mental Disorders Only and Co-occurring Disorders
    Fleury, Marie-Josee
    Grenier, Guy
    Bamvita, Jean-Marie
    Caron, Jean
    PSYCHIATRIC QUARTERLY, 2015, 86 (03) : 355 - 371
  • [3] Profiles Associated Respectively with Substance Dependence Only, Mental Disorders Only and Co-occurring Disorders
    Marie-Josée Fleury
    Guy Grenier
    Jean-Marie Bamvita
    Jean Caron
    Psychiatric Quarterly, 2015, 86 : 355 - 371
  • [4] Adherence to pharmacotherapy in bipolar disorder patients with and without co-occurring substance use disorders
    Manwani, Sumita G.
    Szilagyi, Kathleen A.
    Zablotsky, Benjamin
    Hennen, John
    Griffin, Margaret L.
    Weiss, Roger D.
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (08) : 1172 - 1176
  • [5] Anxiety disorders among patients with co-occurring bipolar and substance use disorders
    Kolodziej, ME
    Griffin, ML
    Najavits, LM
    Otto, MW
    Greenfield, SF
    Weiss, RD
    DRUG AND ALCOHOL DEPENDENCE, 2005, 80 (02) : 251 - 257
  • [6] Interventions for HIV Clients with Co-Occurring Substance Use and Personality Disorders
    Willinger, Barbara I.
    SOCIAL WORK IN HEALTH CARE, 2010, 49 (05) : 444 - 457
  • [7] Demoralization in Patients With Substance Use and Co-Occurring Psychiatric Disorders
    De Weert, Gerdien H.
    Markus, Wiebren
    Kissane, David W.
    De Jong, Cornelis A. J.
    JOURNAL OF DUAL DIAGNOSIS, 2017, 13 (02) : 136 - 143
  • [8] Psychotropic medication management in persons with co-occurring psychiatric and substance use disorders
    Sowers, W
    Golden, S
    JOURNAL OF PSYCHOACTIVE DRUGS, 1999, 31 (01) : 59 - 70
  • [9] Current Status of Co-Occurring Mood and Substance Use Disorders: A New Therapeutic Target
    Pettinati, Helen M.
    O'Brien, Charles P.
    Dundon, William D.
    AMERICAN JOURNAL OF PSYCHIATRY, 2013, 170 (01): : 23 - 30
  • [10] Caring for patients with co-occurring mental health & substance use disorders
    Rundell, Kristen
    Oza, Rupal
    Greco, Laurie
    Cruzado, Ernesto Ortiz
    JOURNAL OF FAMILY PRACTICE, 2019, 68 (07): : 400 - 404